An Outbreak of β -Lactamase Klebsiella Pneumoniae Carbapenemase 2–Producing Klebsiella Pneumoniae Bacteremia in Hematology Patients

Carbapenems are frequently used for severe hospital infections caused by K. pneumoniae, especially when isolates produce extended-spectrum β-lactamases...

[1]  N. Petrosillo,et al.  Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art , 2013, Expert review of anti-infective therapy.

[2]  A. Haidich,et al.  Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. , 2011, The Lancet. Infectious diseases.

[3]  N. Woodford,et al.  Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. , 2011, FEMS microbiology reviews.

[4]  G. Daikos,et al.  Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  D. Morgan,et al.  Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria , 2011, Southern medical journal.

[6]  S. Pournaras,et al.  Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. , 2010, The Journal of antimicrobial chemotherapy.

[7]  A. Armaganidis,et al.  An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  K. Riesenberg,et al.  Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia , 2009, Infection Control & Hospital Epidemiology.

[9]  A. Maniatis,et al.  Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. , 2009, The Journal of antimicrobial chemotherapy.

[10]  V. Raftopoulos,et al.  Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). , 2009, The Journal of infection.

[11]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.

[12]  A. Vatopoulos.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  B. Olsson-Liljequist,et al.  Identification of Klebsiella pneumoniae carbapenemase in Sweden. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  Yehuda Carmeli,et al.  Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.

[15]  P. Nordmann,et al.  Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Klebsiella pneumoniae Isolate from Greece , 2007, Antimicrobial Agents and Chemotherapy.

[16]  E. Chachaty,et al.  Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. , 2007, The Journal of antimicrobial chemotherapy.

[17]  N. Høiby,et al.  Class A carbapenemases. , 2007, The Journal of antimicrobial chemotherapy.

[18]  Y. Carmeli,et al.  Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital , 2007, Antimicrobial Agents and Chemotherapy.

[19]  John Quale,et al.  Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection , 2005, Antimicrobial Agents and Chemotherapy.

[20]  John Quale,et al.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. , 2005, Archives of internal medicine.

[21]  Neil Woodford,et al.  Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center , 2004, Antimicrobial Agents and Chemotherapy.

[22]  P. Bradford,et al.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Paterson,et al.  Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  V. Miriagou,et al.  VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek Hospitals , 2003, Journal of Clinical Microbiology.

[25]  M. Hussain,et al.  Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies. , 2001, The Journal of infection.

[26]  Iraida E. Robledo,et al.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.